The role of tumor necrosis factor α in down-regulation of osteoblast Phex gene expression in experimental murine colitis

被引:38
作者
Uno, Jennifer K.
Kolek, Olga I.
Hines, Eric R.
Xu, Hua
Timmermann, Barbara N.
Kiela, Pawel R.
Ghishan, Fayez K.
机构
[1] Univ Arizona, Dept Pediat, Hlth Sci Ctr, Steele Childrens Res Ctr, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Physiol, Hlth Sci Ctr, Steele Childrens Res Ctr, Tucson, AZ 85724 USA
[3] Univ Arizona, Coll Pharm, Arizona Ctr Phytomed Res, Tucson, AZ 85721 USA
[4] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
关键词
D O I
10.1053/j.gastro.2006.05.020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Reduced bone mass is a common complication of inflammatory bowel disease (IBD), although the mechanisms that contribute to osteopenia are not completely understood. Tumor necrosis factor alpha (TNF-alpha is up-regulated in patients with IBD and has detrimental effects on osteoblasts. Phex gene is expressed predominantly in osteoblasts, and its disruption results in defective bone mineralization. The aim of this study was to evaluate whether TNF-alpha regulates Phex gene expression thus contributing to the abnormal bone metabolism observed in IBD. Methods: Phex gene expression was evaluated in calvaria of 6-7-week-old mice administered with trinitrobenzene sulfonic acid (TNBS) with or without neutralizing anti-TNF-alpha antibody, dietary curcumin, or systemically with recombinant TNF-alpha. TNF-alpha-treated UMR-106 osteoblasts were also examined. Phex promoter activity was assayed in transiently transfected TNF-a-treated UMR-106 cells. Results: Compared with control animals, Phex messenger RNA (mRNA) expression decreased by 40%-50% in both TNBS colitis and TNF-alpha-injected mice. Dietary curcumin and anti-TNF-a antibody counteracted the detrimental effect of TNBS on Phex gene expression. TNF-alpha-treated UMR-106 cells showed a concentration-dependent and transcriptionally mediated decrease in Phex mRNA and gene promoter activity, with the -133 to -74 bp region of the Phex promoter likely involved in the mechanism of TNF-alpha action. Coinciding with decreased Phex protein level, TNF-alpha drastically reduced mineralization in UMR-106 osteoblasts. Conclusions: Acute colitis and TNF-alpha decrease Phex mRNA and protein expression via a transcriptional mechanism. TNF-alpha-mediated reduction in Phex protein is at least in part responsible for inhibition of osteoblast mineralization, and the described mechanism may contribute to the abnormal bone metabolism associated with IBD.
引用
收藏
页码:497 / 509
页数:13
相关论文
共 59 条
[1]
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's disease [J].
Abreu, MT ;
Geller, JL ;
Vasiliauskas, EA ;
Kam, LY ;
Vora, P ;
Martyak, LA ;
Yang, HY ;
Hu, B ;
Lin, YC ;
Keenan, G ;
Price, J ;
Landers, CJ ;
Adams, JS ;
Targan, SR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (01) :55-63
[2]
Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density [J].
Abreu, MT ;
Kantorovich, V ;
Vasiliauskas, EA ;
Gruntmanis, U ;
Matuk, R ;
Daigle, K ;
Chen, S ;
Zehnder, D ;
Lin, YC ;
Yang, H ;
Hewison, M ;
Adams, JS .
GUT, 2004, 53 (08) :1129-1136
[3]
Another look at fracture risk in IBD [J].
Bernstein, CN .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) :886-887
[4]
Review article: Osteoporosis and inflammatory bowel disease [J].
Bernstein, CN ;
Leslie, WD .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (09) :941-952
[5]
Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease [J].
Bernstein, M ;
Irwin, S ;
Greenberg, GR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09) :2031-2035
[6]
Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[7]
CURCUMIN, AN ANTITUMOR PROMOTER AND ANTIINFLAMMATORY AGENT, INHIBITS INDUCTION OF NITRIC-OXIDE SYNTHASE IN ACTIVATED MACROPHAGES [J].
BROUET, I ;
OHSHIMA, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (02) :533-540
[8]
Interleukin-10 knockout mouse: A model for studying bone metabolism during intestinal inflammation [J].
Cohen, SL ;
Moore, AM ;
Ward, WE .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) :557-563
[9]
Ontogeny of basolateral membrane sodium-hydrogen exchange (NHE) activity and mRNA expression of NHE-1 and NHE-4 in rat kidney and jejunum [J].
Collins, JF ;
Xu, H ;
Kiela, PR ;
Zeng, JM ;
Ghishan, FK .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1369 (02) :247-258
[10]
Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones [J].
Dresner-Pollak, R ;
Gelb, N ;
Rachmilewitz, D ;
Karmeli, F ;
Weinreb, M .
GASTROENTEROLOGY, 2004, 127 (03) :792-801